The Mission of The Foundation Fighting Blindness is to find the causes, treatments, preventions, and cures for retinitis pigmentosa (RP), macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases. Since its inception in 1971, The Foundation has raised more than $700 million. Each year, funds raised for research are released directly to The Foundation Fighting Blindness Scientific Programs. The Foundation Fighting Blindness administers a comprehensive group of Scientific Programs strategically designed to accomplish its mission. These include the Grants and Awards Programs consisting of individual and multi-investigator awards as well as career development awards for early career clinician-scientists. The Foundation Fighting Blindness is the world’s leading non-governmental source of research funding for retinal degenerative diseases.
The Grants and Awards Programs of the Foundation Fighting Blindness support basic, laboratory-based early translational, clinical studies and pre-clinical research applicable to a broad range of retinal degenerative diseases. Awards are made through a competitive funding mechanism. Currently, only those proposals of the highest scientific merit that will advance the goals and objectives of The Foundation Fighting Blindness are considered for funding.
The urgent mission of the Foundation Fighting Blindness is to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa, age-related macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases. The Foundation is a beacon for those affected by these blinding diseases. Join the fight and help us accelerate our mission.
Welcome to the new Foundation site — supported in partnership with Genentech, A Member of the Roche Group.
